Advertisement

Distribution of Methylated Regions Within gDNA in Acute and Chronic Phases of Diabetes Mellitus

  • Alexey A. Leontovich
  • Michael P. SarrasJr.Email author
Reference work entry

Abstract

Diabetes mellitus (DM) is a disease of metabolic dysregulation involving the induction of hyperglycemia due to (1) loss of functioning of pancreatic beta cells that produce insulin (t1 DM) or (2) the inability of systemic cells to properly respond to the insulin signal (t2 DM). The resulting hyperglycemic episodes induce long-term complications in a broad spectrum of organs/tissues such as seen in the cardiovascular system (CV). One aspect of CV dysregulation is seen in abnormalities in blood vessel formation (BVF). These abnormalities in BVF are seen in the acute and chronic states of DM, with the latter chronic effects termed “metabolic memory” (MM). The heritable nature of metabolic memory indicates a role for the epigenome as a contributing factor in DM and MM. In this regard, the epigenome is comprised of all chromatin-modifying processes such as DNA methylation and histone modifications that allow cells and organisms to quickly respond to changing environmental stimuli. The current review focuses on the global patterns of gDNA methylation in Control, DM, and MM groups using a zebrafish DM/MM model of the disease. For this review, global analysis is focused on 10 Kb upstream from the TSS (transcription start site), 1 Kb upstream from the TSS, and 300 bp downstream of the TSS for all genes of the zebrafish genome. Analysis of gDNA methylation patterns will also be studied in regard to genes that regulate BVF, and we have included genes that control DNA replication and repair in this regulatory group. As will be discussed, hyperglycemia not only induces changes in gDNA methylation but complex changes in the pattern seen in the methylation and demethylation of BVF regulatory genes.

Keywords

Diabetes mellitus Zebrafish Metabolic memory Epigenetics DNA methylation Chromatin Promoters Hypomethylation Hypermethylation Bioinformatics 

List of Abbreviations

AGE

Advanced glycation end products

CH3

Methyl group

CpG

Cytosine-phosphate-guanine

DM

Diabetes mellitus

gDNA

Genomic DNA

MeDIP

Methylated DNA immunoprecipitation

MM

Metabolic memory

MRs

Methylated regions

MSs

Methylated sites

ROS

Reactive oxygen species

STZ

Streptozotocin

TF

Transcription factor

TSS

Transcription start site

References

  1. Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40(4):405–412CrossRefGoogle Scholar
  2. Blankenberg D, Kuster G, Coraor N, Ananda G, Lazarus R, Mangan M, Nekrutenko A, Taylor J (2010) Galaxy: a web-based genome analysis tool for experimentalists. Curr Protocol Mol Biol 19:11–21. SRC – GoogleScholar: 1–2Google Scholar
  3. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54(6):1615–1625CrossRefGoogle Scholar
  4. Capiotti KM, Antonioli R Jr, Kist LW, Bogo MR, Bonan CD, Da Silva RS (2014) Persistent impaired glucose metabolism in a zebrafish hyperglycemia model. Comp Biochem Physiol B Biochem Mol Biol 171:58–65CrossRefGoogle Scholar
  5. Chan PS, Kanwar M, Kowluru RA (2010) Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory. J Diabetes Complicat 24(1):55–63CrossRefGoogle Scholar
  6. Costa P, Soares R (2013) Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox. Life Sci 92(22):1037–1045CrossRefGoogle Scholar
  7. Dolinoy DC, Jirtle RL (2008) Environmental epigenomics in human health and disease. Environ Mol Mutagen 49(1):4–8CrossRefGoogle Scholar
  8. Dunoyer-Geindre S, Rivier-Cordey AS, Caetano C, Fish RJ, Kruithof EK (2016) Effect of regulatory element DNA methylation on tissue-type plasminogen activator gene expression. PLoS One 11(12):e0167588CrossRefGoogle Scholar
  9. Engerman RL, Kern TS (1987) Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36(7):808–812CrossRefGoogle Scholar
  10. Goecks J, Nekrutenko A, Taylor J (2010) Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 11(8):R86CrossRefGoogle Scholar
  11. Hammes HP, Klinzing I, Wiegand S, Bretzel RG, Cohen AM, Federlin K (1993) Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat. Invest Ophthalmol Vis Sci 34(6):2092–2096PubMedGoogle Scholar
  12. Han Y, He X (2016) Integrating epigenomics into the understanding of biomedical insight. Bioinform Biol Insights 10:267–289CrossRefGoogle Scholar
  13. Inzucchi S, Majumdar S (2015) Glycemic targets: what is the evidence? Med Clin N Am 99(1):47–67CrossRefGoogle Scholar
  14. Jhamb S, Vangaveti VN, Malabu UH (2016) Genetic and molecular basis of diabetic foot ulcers: clinical review. J Tissue Viability 25(4):229–236CrossRefGoogle Scholar
  15. Kimmel RA, Dobler S, Schmitner N, Walsen T, Freudenblum J, Meyer D (2015) Diabetic pdx1-mutant zebrafish show conserved responses to nutrient overload and anti-glycemic treatment. Sci Rep 5:14241CrossRefGoogle Scholar
  16. Leontovich AAIRV, Sarras MP Jr (2016) Epigenetic studies point to DNA replicaton/repair genes as a basis for the heritable nature of long term complications in diabetes. J Diabetes Res 2016:1–10CrossRefGoogle Scholar
  17. Liew G, Wong VW, Ho IV (2017) Mini review: changes in the incidence of and progression to proliferative and sight-threatening diabetic retinopathy over the last 30 years. Ophthalmic Epidemiol 24:73–80. 1–8CrossRefGoogle Scholar
  18. Morgan DK, Whitelaw E (2008) The case for transgenerational epigenetic inheritance in humans. Mamm Genome Off J Int Mamm Genome Soc 19(6):394–397CrossRefGoogle Scholar
  19. Olsen AS, Sarras MP, Intine RV (2010) Limb regeneration is impaired in an adult zebrafish model of diabetes mellitus. Wound Repair Regen Off Publ Wound Healing Soc Eur Tissue Repair Soc 18(5):532–542Google Scholar
  20. Olsen AS, Sarras MP, Leontovich A, Intine RV,D (2012) Heritable transmission of diabetic metabolic memory in zebrafish correlates with and aberrant gene expression. Diabetes 61(2):485–491CrossRefGoogle Scholar
  21. Patschan D, Muller GA (2016) Acute kidney injury in diabetes mellitus. Int J Nephrol 2016:6232909CrossRefGoogle Scholar
  22. Prattichizzo F, Giuliani A, Ceka A, Rippo MR, Bonfigli AR, Testa R, Procopio AD, Olivieri F (2015) Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes. Clin Epigenetics 7(1):56CrossRefGoogle Scholar
  23. Putta S, Lanting L, Sun G, Lawson G, Kato M, Natarajan R (2012) Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol JASN 23(3):458–469CrossRefGoogle Scholar
  24. Rando OJ (2012) Combinatorial complexity in chromatin structure and function: revisiting the histone code. Curr Opin Genet Dev 22(2):148–155CrossRefGoogle Scholar
  25. Riddle MC (2010) Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation 122(8):844–846CrossRefGoogle Scholar
  26. Roy S, Sala R, Cagliero E, Lorenzi M (1990) Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci U S A 87(1):404–408CrossRefGoogle Scholar
  27. Sarras MP, Leontovich AA, Olsen AS, Intine RV (2013) Impaired tissue regeneration corresponds with altered expression of developmental genes that persists in the metabolic memory state of diabetic zebrafish. Wound Repair Regen Off Publ Wound Healing Soc Eur Tissue Repair Soc 21(2):320–328Google Scholar
  28. Sarras MP Jr, Mason S, McAllister G, Intine RV (2014) Inhibition of poly-ADP ribose polymerase enzyme activity prevents hyperglycemia-induced impairment of angiogenesis during wound healing. Wound Repair Regen 22(5):666–670CrossRefGoogle Scholar
  29. Sarras MP Jr, Leontovich AA, Intine RV (2015) Use of zebrafish as a model to investigate the role of epigenetics in propagating the secondary complications observed in diabetes mellitus. Comp Biochem Physiol C Toxicol Pharmacol 178:3–7CrossRefGoogle Scholar
  30. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EAM, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS, American Diabetes Association, American College of Cardiology Foundation, American Heart Association (2009) Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 32(1):187–192CrossRefGoogle Scholar
  31. Spitz F, Furlong EE (2012) Transcription factors: from enhancer binding to developmental control. Nat Rev Genet 13(9):613–626CrossRefGoogle Scholar
  32. Yoon Y-S (2013) Reprogramming diabetic stem or progenitor cells for treating diabetic complications. Trans-NIH Angiogenesis Workshop, Division of Cancer Prevention. Lister Hill, NIH Main Campus, Division of Cancer PreventionGoogle Scholar
  33. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, Liu XS (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9(9):R137CrossRefGoogle Scholar
  34. Zhang H, Cai X, Yi B, Huang J, Wang J, Sun J (2014) Correlation of CTGF gene promoter methylation with CTGF expression in type 2 diabetes mellitus with or without nephropathy. Mol Med Rep 9(6):2138–2144CrossRefGoogle Scholar
  35. Zhang Q, Lenardo MJ, Baltimore D (2017) 30 years of NF-kappaB: a blossoming of relevance to human pathobiology. Cell 168(1–2):37–57CrossRefGoogle Scholar
  36. Zhong Q, Kowluru RA (2010) Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon. J Cell Biochem 110(6):1306–1313CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Biomedical Statistics and InformaticsMayo ClinicRochesterUSA
  2. 2.Department of Cell Biology and Anatomy, Chicago Medical SchoolRosalind Franklin University of Medicine and ScienceNorth ChicagoUSA

Personalised recommendations